Vincent T. Jr. Devita
#76,623
Most Influential Person Now
Vincent T. Jr. Devita's AcademicInfluence.com Rankings
Vincent T. Jr. Devitamedical Degrees
Medical
#647
World Rank
#865
Historical Rank
Oncology
#16
World Rank
#17
Historical Rank
Download Badge
Medical
Why Is Vincent T. Jr. Devita Influential?
(Suggest an Edit or Addition)Vincent T. Jr. Devita's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cancer : Principles and Practice of Oncology (1982) (7969)
- A history of cancer chemotherapy. (2008) (1321)
- Combination chemotherapy in the treatment of advanced Hodgkin's disease. (1970) (1106)
- Aspergillosis. The spectrum of the disease in 98 patients. (1970) (958)
- IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. (1980) (821)
- Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. (1978) (712)
- Important advances in oncology (1991) (667)
- DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology (2015) (492)
- DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology (2015) (492)
- ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE RESULTS WITH COMBINATION CHEMOTHERAPY (1975) (476)
- Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. (1980) (450)
- Twenty years of MOPP therapy for Hodgkin's disease. (1986) (409)
- Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. (1983) (379)
- Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer (1975) (377)
- Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. (1992) (364)
- Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. (1976) (354)
- Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. (1972) (334)
- Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. (1972) (332)
- The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. (1988) (329)
- SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSION (1975) (328)
- Clinical pharmacology of cyclophosphamide. (1973) (316)
- Biologic Therapy of Cancer (1992) (315)
- Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. (1978) (303)
- Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. (1968) (295)
- Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy. (1973) (257)
- Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. (1980) (256)
- American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. (1975) (256)
- Histologic progression in non-Hodgkin's lymphoma. (1982) (238)
- Two hundred years of cancer research. (2012) (236)
- Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. (1977) (228)
- Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited. (1976) (228)
- Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. (1972) (220)
- Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute. (1981) (218)
- Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. (1991) (217)
- Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. (1979) (217)
- Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. (1987) (215)
- AIDS: Etiology, Diagnosis, Treatment, and Prevention (1992) (215)
- Report of the Committee on Hodgkin's Disease Staging Procedures. (1971) (209)
- The james ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer (1983) (207)
- Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. (1981) (192)
- Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. (1984) (192)
- The use of drugs in combination for the treatment of cancer: rationale and results. (1973) (191)
- A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. (1976) (185)
- Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma. (1976) (176)
- Clinical antitumor activity and toxicity of streptozotocin (NSC‐85998) (1974) (176)
- Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma. (1981) (171)
- Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. (1988) (165)
- Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma. (1974) (162)
- The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lecture (1981) (161)
- American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations. (1975) (159)
- Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. (1983) (158)
- Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. (1971) (157)
- Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy. (1979) (152)
- Clinical relevance of the histopathological subclassification of diffuse "histiocytic" lymphoma. (1978) (149)
- Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma. (1974) (147)
- NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. (1984) (147)
- Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management. (1988) (147)
- The calculation of actual or received dose intensity: a comparison of published methods. (1991) (147)
- Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. (1979) (145)
- Trials and tribulations (2008) (140)
- Familial chronic lymphocytic leukemia. (1969) (136)
- Combination chemotherapy for advanced breast cancer: response and effect on survival. (1976) (130)
- Risk of new cancers in patients with Hodgkin's disease (1977) (130)
- A decade of combination chemotherapy of advanced Hodgkin's disease (1972) (127)
- Treatment of Hodgkin lymphoma: a 50-year perspective. (2014) (127)
- Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease. (1980) (126)
- Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. (1989) (123)
- Characteristics of blast crisis in chronic granulocytic leukemia. (1977) (121)
- Pneumocystis carinii: the spectrum of diffuse interstitial pneumonia in patients with neoplastic diseases. (1970) (121)
- High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer. (1981) (112)
- Malignant lymphoma I. The histology and staging of 473 patients at the national cancer institute (1982) (112)
- Dose-response is alive and well. (1986) (111)
- Prolonged initial remission in patients with nodular mixed lymphoma. (1984) (103)
- Diffuse histiocytic lymphoma involving the gastrointestinal tract (1978) (102)
- Cancer: Principles & Practice of Oncology: Annual Advances in Oncology (2012) (102)
- Cyclical Combination Chemotherapy for Advanced Breast Carcinoma (1974) (102)
- Malignant lymphoma II. Prognostic factors and response to treatment of 473 patients at the national cancer institute (1982) (101)
- Maintenance chemotherapy for advanced Hodgkin's disease in remission. (1973) (100)
- Treatment of ovarian carcinoma: possibilities for progress. (1972) (100)
- CELL CYCLE CHARACTERISTICS OF HUMAN SOLID TUMORS IN VIVO (1970) (98)
- Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance. (1974) (97)
- Ovarian carcinoma metastatic to the diaphragm--frequently undiagnosed at laparotomy. A preliminary report. (1973) (96)
- The American Burkitt Lymphoma Registry: a progress report. (1975) (95)
- Physicians' Cancer Chemotherapy Drug Manual (2016) (95)
- Developmental therapeutics and the acquired immunodeficiency syndrome. (1987) (90)
- The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease. (1986) (87)
- Streptozotocin for malignant insulinomas and carcinoid tumor. Report of eight cases and review of the literature. (1973) (86)
- Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment. (1991) (86)
- Breast Cancer Therapy: Exercising All Our Options (1989) (86)
- Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma (1970) (85)
- Hodgkin's disease. (1993) (84)
- We have met the enemy and he is us! (2009) (80)
- Perspectives on research in gynecologic oncology. Treatment protocols (1976) (80)
- Pseudohyperkalemia due to release of potassium from white blood cells during clotting. (1966) (79)
- Liver biopsy in Hodgkin's disease. Clinicopathologic correlations in 127 patients. (1972) (78)
- Peritoneoscopy: a valuable staging tool in ovarian carcinoma. (1975) (73)
- BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study. (1984) (71)
- Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival. (1973) (69)
- Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations. (1980) (69)
- Pneumocystis carinii pneumonia. (1958) (68)
- Animal toxicology for early clinical trials with anticancer agents. (1981) (66)
- Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survival. (1980) (66)
- Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa–acne inversa: evidence from the national Italian registry (2016) (65)
- Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup. (1977) (65)
- Initial clinical trials with methyl‐ccnu 1‐(2‐chloroethyl)‐3‐(4‐methyl cyclohexyl)‐1‐nitrosourea (meccnu) (1973) (64)
- Physiologic disposition of 1‐(2‐chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea (CCNU) and 1‐(2‐chloroethyl)‐3‐(4‐methyl cyclohexyl)‐1‐nitrosourea (MeCCNU) in man (1973) (64)
- The role of chemotherapy in diffuse aggressive lymphomas. (1988) (63)
- The chemotherapy of Hodgkin's disease. Past experiences and future directions (1978) (61)
- Phytohemagglutinin-induced lymphocyte transformation: the relationship to prognosis of Hodgkin's disease. (1972) (61)
- Approaches to improving the chemotherapy of Hodgkin's disease. (1966) (60)
- Combination chemotherapy for advanced Hodgkin's disease in relapse following extensive radiotherapy (1972) (59)
- Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy. (1976) (58)
- Peritoneoscopy in the staging of Hodgkin's disease. (1971) (57)
- Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in previously treated patients with Hodgkin's disease. (1970) (57)
- The evolution of therapeutic research in cancer. (1978) (57)
- Pneumocystis carinii pneumonia: successful diagnosis treatment of two patients with associated malignant processes. (1969) (56)
- Staging of non-Hodgkin's lymphoma. (1980) (56)
- Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination. (1977) (55)
- Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP. (1991) (54)
- Lymphocyte reactivity in Hodgkin's disease: a lymphocyte civil war. (1973) (53)
- Natural history of malignant lymphomas with divergent histologies at staging evaluation (1981) (53)
- Treatment of Hodgkin's disease using intensive chemotherapy followed by irradiation. (1976) (52)
- Chronic granulocytic leukemia without the Philadelphia chromosome. (1976) (51)
- Hodgkin's disease in childhood. (1973) (51)
- The chemotherapy of ovarian carcinoma (1974) (50)
- Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU. (1971) (50)
- Progress in cancer management. Keynote address (1983) (49)
- Non‐Hodgkin's lymphoma: Patterns of relapse from complete remission after combination chemotherapy (1975) (48)
- Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. (1982) (48)
- he determination of pentamidine (4,4'-diamidinophenoxypentane) in plasma, urine, and tissues. (1970) (47)
- Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamide. (1974) (46)
- Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease. (1997) (45)
- The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications. (1980) (45)
- Abnormalities of tryptophan metabolism and plasma pyridoxal phosphate in Hodgkin's disease. (1970) (43)
- Current concepts of leukemia and lymphoma: etiology, pathogenesis, and therapy. (1976) (43)
- Perspectives in the treatment of breast cancer: 1976. (1977) (42)
- Sequential staging in non-Hodgkin's lymphoma. (1977) (41)
- Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy. (1994) (41)
- Treatment of the lymphomas. (1972) (41)
- Aspergillus lobar pneumonia. (1969) (41)
- Sequential nonsurgical and surgical staging of non‐Hodgkin's lymphoma (1978) (38)
- Clinical study with bleomycin: Tolerance to twice weekly dosage (1972) (38)
- Meningeal leukemia in the blastic phase of chronic granulocytic leukemia. (1975) (37)
- Announcement of formation of: The lymphoma task force and pathology reference center (1968) (37)
- DeVita, Hellman, and Rosenberg's cancer : (2013) (37)
- The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210. (1970) (36)
- A computer data base for information on cancer treatment. (1987) (35)
- Liver‐spleen scan in hodgkin's disease (1973) (35)
- Pathological staging of 100 consecutive untreated patients with non‐Hodgkin's lymphomas. Extramedullary sites of disease (1976) (35)
- The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo. (1969) (34)
- Splenectomy in the chronic phase of chronic granulocytic leukemia. Effects in 32 patients. (2020) (34)
- Clinical cancer research: the past, present and the future (2014) (33)
- Adjuvant Therapy for Node-Negative Breast Cancer (1989) (33)
- Immunological and physiological responses to whole-body hyperthermia. (1982) (32)
- Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. (1975) (32)
- Preliminary clinical studies with ibenzmethyzin (1966) (32)
- Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma. (1978) (32)
- Intensive chemotherapy for Hodgkin's disease: long-term complications. (1973) (31)
- The effect of combined modality therapy on local control and survival. (1986) (31)
- SOME PHARMACOLOGIC PROPERTIES OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213). (1964) (31)
- Combined modality treatment of American Burkittapos;s lymphoma (1976) (30)
- A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non‐Hodgkin's lymphoma (1979) (30)
- Hodgkin's disease--clinical trials and travails. (2003) (29)
- Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma (1981) (29)
- Chemotherapy for Hodgkin's disease: the remaining challenges. (1982) (28)
- Toward a personalized treatment of Hodgkin's disease. (2010) (27)
- The influence of information on drug resistance on protocol design. (1991) (27)
- Role of Chemotherapy in Hodgkin’s Lymphoma (2009) (26)
- Pneumocystis Pneumonia: The Importance of Early Open Lung Biopsy (1976) (26)
- Patterns of involvement with malignant lymphoma and implications for treatment decision making. (1975) (25)
- Comprar DeVita. Cancer: Principles and Practice of Oncology , 9/e | Steven A. Rosenberg | 9781451118131 | Lippincott Williams & Wilkins (2011) (24)
- Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan. (1975) (24)
- Severe vinblastine-induced leukopenia during late pregnancy with delivery of a normal infant. (1968) (24)
- Needle biopsy in pseudocystis carinii pneumonia. (1969) (24)
- Bone-marrow biopsy in Hodgkin's disease. (1968) (23)
- Pigmentation due to a new antitumor agent. Effects of topical application of BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea]. (1966) (23)
- Chemotherapeutic implications of staging in Hodgkin's disease. (1971) (23)
- Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomata. (1975) (23)
- Anergy and tryptophan metabolism in Hodgkin's disease. (1971) (23)
- Cancer Genes (1996) (23)
- Treatment of Hodgkin's disease. (1967) (23)
- Antitumor activity and some pharmacologic properties of anthramycin methyl ether. (1968) (23)
- Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects. (1979) (22)
- Comprar Cancer: Principles & Practice of Oncology, 2ª Ed. Primer Of The Molecular Biology Of Cancer | Vincent T. DeVita Jr. | 9781496310637 | Lippincott Williams & Wilkins (2015) (22)
- The clinical trials system is broken (2008) (21)
- Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas. (1991) (21)
- Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. (1976) (21)
- The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs. (1970) (20)
- Hypercalcemia in chronic granulocytic leukemia (1971) (19)
- Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle. (1971) (19)
- Conflict of interest disclosures (2010) (19)
- A selective history of the therapy of Hodgkin's disease (2003) (19)
- Radiotherapeutic implications of prospective staging in non-Hodgkin's lymphoma. (1974) (19)
- Progress in Oncology (2001) (19)
- Human models of human diseases; breast cancer and the lymphomas. (1979) (18)
- Dose Intensity (1993) (18)
- Preliminary clinical trials of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma. (1972) (18)
- New anticancer drugs. (1978) (17)
- Renal involvement in diffuse aggressive lymphomas: results of treatment with combination chemotherapy. (1985) (17)
- PULMONARY MANIFESTATIONS OF PRIMARY HEPATIC CARCINOMA (1965) (15)
- In vitro granulocyte production in patients with Hodgkin's disease and lymphocytic, histiocytic, and mixed lymphomas. (1975) (15)
- Pneumocystis pneumonia in patients with cancer: clinical setting. (1976) (15)
- Studies on the Anti-Tumor Action of Poly I: Poly C (1971) (15)
- Combination chemotherapy and survival in advanced Hodgkin's disease. (1973) (14)
- Cancer as a preventable disease. (1985) (14)
- Results of combination chemotherapy of non-Hodgkin's lymphoma. (1975) (14)
- Changing patterns of Hodgkin's disease at autopsy: a 25-year experience at the National Cancer Institute, 1953--1978. (1982) (13)
- The 'War on Cancer' and its impact (2004) (13)
- Cancer drug development (1979) (13)
- The curse of the cure (2005) (13)
- The Physician Data Query (PDQ) cancer information system. (1986) (13)
- HL-A antigens in Hodgkin's disease; histopathologic and clinical correlations. (1974) (12)
- A Prospective Trial of Radiation Alone vs Combination Chemotherapy Alone for Early-Stage Hodgkin’s Disease: Implications of 25-Year Follow-Up to Current Combined Modality Therapy. (2006) (12)
- The Framework Convention on Tobacco Control (2005) (12)
- The current status of NCI trials in Hodgkin’s disease (1985) (12)
- Late sequelae of treatment of Hodgkin's disease. (1997) (12)
- Peritoneoscopy: a technique to evaluate therapeutic efficacy in non-Hodgkin's lymphoma patients. (1977) (12)
- Perspectives on research in gynecologic oncology. (1976) (12)
- Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma. (1975) (12)
- A Perspective on the War on Cancel (2002) (12)
- Chemotherapy of Hodgkin's disease. (1979) (11)
- Comprar DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 10e | V. DeVita | 9781451192940 | Lippincott Williams & Wilkins (2015) (11)
- Comprar DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 10e | V. DeVita | 9781451192940 | Lippincott Williams & Wilkins (2015) (11)
- The evolution of primary multimodality treatment in resectable breast cancer (1980) (11)
- High dose intravenous bleomycin in the treatment of advanced lymphomas. (1975) (11)
- High-dose intermittent intravenous infusion of procarbazine (NSC-77213). (1973) (11)
- The cell cycle: Probing new molecular determinants of resistance and sensitivity to cytotoxic agents. (1995) (11)
- Governance of science at the National Cancer Institute: perceptions and opportunities in oncogene research. (1984) (11)
- Late recurrence of testicular tumor. (1972) (10)
- Hematology in 2010: New therapies and standard of care in oncology (2011) (10)
- Natural history of malignant melanoma as related to therapy. (1976) (10)
- Abnormal coagulation results in patients with Hodgkin's disease. (1985) (10)
- RECENTLY RECOGNIZED COMPLICATIONS OF CANCER CHEMOTHERAPY (1974) (10)
- PDQ: an innovation in information dissemination linking cancer research and clinical practice. (1987) (10)
- Infection and Cancer: Old Friends (1973) (10)
- Progress in the Treatment of Hodgkin's Lymphoma. (2017) (10)
- Primary chemotherapy can avoid mastectomy, but there is more to it than that. (1990) (10)
- Hodgkin's disease. (1971) (10)
- Cancer : principles & practice of oncology : primer of the molecular biology of cancer/ editors, Vincent T. DeVita, Jr, Theodore S. Lawrence, Steven A. Rosenberg; with 82 contributing authors (2015) (10)
- Therapeutic implications of the new biology. (2000) (9)
- Hodgkin's disease: the salvage of radiation treatment failures. (1977) (9)
- Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas. (1981) (9)
- Herceptin: HERalding a new era in breast cancer care but at what cost? (2005) (8)
- Relationship of normal CDF1 mouse leukocyte kinetics to growth characteristics of leukemia L1210. (1969) (8)
- Cancer Prevention Awareness Program: targeting black Americans. (1985) (8)
- The Provenge® decision (2007) (8)
- The Holy Grail of biomarkers (2009) (7)
- Treatment of Pneumocystis carinii pneumonia: current status of the regimens of pentamidine isethionate and pyrimethamine-sulfadiazine. (1976) (7)
- The era of personalized medicine: back to basics (2008) (7)
- PNEUMOCYSTIS CARINII PNEUMONIA AND PENTAMIDINE ISETHIONATE TOXICITY (1968) (6)
- The lymphomas: biologic implications of therapy and therapeutic implications of the new biology. (1987) (6)
- A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion. (2000) (6)
- Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma. (1981) (6)
- Comprar Colon And Other Gastrointestinal Cancers (From Cancer Principles And Practice Of Oncology, 10th Edition) | Vincent T. DeVita Jr. | 9781496333964 | Lippincott Williams & Wilkins (2016) (6)
- Carcinoma of the Breast: Status of Adjuvant Medical Treatment (1976) (6)
- The governance of science at the National Cancer Institute: a perspective on misperceptions. (1983) (6)
- CHOP versus intensive regimens in non-Hodgkin's lymphoma. (1993) (5)
- National Oncology Forum: perspectives for the year 2000. (2001) (5)
- Löffler's Syndrome as a complication of bipedal lymphangiography. (1970) (5)
- What are clinical trials all about? (1985) (5)
- Off-label use of approved drugs (2009) (5)
- Clinical characteristics of Pneumocystis carinii pneumonia. (1979) (5)
- The evolution of chemotherapy of lymphomas of adults. (1987) (5)
- Combined modality treatment of American Burkitt's lymphoma. (1976) (5)
- Research: The moving parts (2013) (4)
- National Institutes of Health consensus development conference on the management of clinically localized prostate cancer (1988) (4)
- The design of clinical trials in the therapy of ovarian carcinoma. (1974) (4)
- CNS Infiltration: A Complication of Diffuse Lymphomas (1979) (4)
- The emergence of biologicals as cancer treatment: the good news and the bad. (1987) (4)
- Radiation therapy is better than chemotherapy in early-stage Hodgkin's disease? Not so fast. (1992) (4)
- Clinical trials with 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) given intravenously. (1972) (4)
- The concept of cure (2006) (4)
- Combination chemotherapy of acute leukemia and lymphoma. (1979) (4)
- Combination therapy of the lymphomas. (1978) (4)
- Proceedings of the Conference on non-Hodgkin's lymphomas: summary of symposium. (1977) (4)
- Combination Chemotherapy of Solid Tumors: An American-Italian Collaboration: A Celebration of the work of Gianni Bonadonna (2016) (4)
- Treatment of refractory splenomegaly in myeloproliferative disease by splenic artery infusion. (1979) (4)
- The role of combined modality therapy in the treatment of stage IIIA Hodgkin's disease. (1979) (4)
- A breakthrough in Hodgkin's disease (2010) (4)
- Hodgkin's disease and transplantation: a room with a (nontransplanter's) view. (1999) (4)
- Hematology in 2010: New therapies and standard of care in oncology (2011) (3)
- In vivo tumor cell kinetic studies: use of local thymidine injection followed by fine-needle aspiration. (1972) (3)
- ProMACE-MOPP combination chemotherapy for diffuse lymphomas. (1985) (3)
- On the value of response criteria in therapeutic research. (1988) (3)
- Delayed hypersensitivity in patients with cancer. (1971) (3)
- The most important news at ASCO 2009 (2009) (3)
- Keeping up with the cancer literature--PDQ ACCESS. (1988) (3)
- We can prevent cancer. (1985) (2)
- Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy. (1981) (2)
- Should the FDA be the doctor of last resort? (2005) (2)
- Randomized comparison of chemotherapy (CVP) and radiotherapy (TBI) in stage III–IV poorly differentiated lymphocytic lymphoma (1978) (2)
- Comprar Prostate And Other Genitourinary Cancers (From Cancer Principles And Practice Of Oncology, 10th Edition) | Vincent T. DeVita Jr. | 9781496333971 | Lippincott Williams & Wilkins (2016) (2)
- The war on cancer has a birthday, and a present. (1997) (2)
- On special initiatives, critics, and the National Cancer Program. (1984) (2)
- DeVita, Jellman, and Rosenberg's cancer : principles & practice of oncology, volume one (2008) (2)
- ANTEPARTUM THROMBOPHLEBITIS AND PULMONARY EMBOLIZATION. REPORT OF A CASE AND REVIEW OF THE LITERATURE. (1965) (2)
- Relationship of Normal CDF 1 Mouse Leukocyte Kinetics to Growth Characteristics of Leukemia (2)
- Contrasting viewpoints on cancer drug development: the Wooldridge and Richardson reports. (1984) (2)
- Comprar Cancer. Principles and practice of oncology. Primer of molecular biology in cancer | V. DeVita | 9781451118971 | Lippincott Williams & Wilkins (2011) (2)
- System of Scientific Advisory Boards at the National Cancer Institute. (1989) (2)
- Some studies on the metabolism of cyclophosphamide. Abstr. (1969) (2)
- Chemotherapy of the Lymphomas (1971) (2)
- Let's return to the “belly bath” (2006) (2)
- Is a mechanism such as the NCI's Clinical Alert ever an appropriate alternative to journal peer review? (1991) (2)
- Comprar Cancer. Principles and practice of oncology. Primer of molecular biology in cancer | V. DeVita | 9781451118971 | Lippincott Williams & Wilkins (2011) (2)
- Is alternating cyclic chemotherapy better than standard four-drug chemotherapy for Hodgkin's disease? No. (1993) (2)
- Nature Clinical Practice Oncology: pound for pound a better choice! (2005) (2)
- A Book Review of: “UICC Manual of Clinical Oncology” (2006) (2)
- The NIH entitlement program (2009) (2)
- Preliminary clinical trials and clinical pharmacologic studies with 5-(3,3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196) given orally. (1971) (2)
- Hodgkin's disease: conference summary and future directions. (1982) (1)
- Governance of science at the national cancer institute: management of resources in an era of scarcity. (1983) (1)
- Shifting paradigms in lung cancer (2005) (1)
- Treatment of diffuse large cell non-Hodgkin’s lymphomas (1985) (1)
- Pneumocystis carinii Pneumonia. (1970) (1)
- Diffuse Small Noncleaved-Cell, Non-Burkitt's Lymphoma in Adults (2016) (1)
- Evolution of the National Cancer Program: an American investment for conquering cancer. (2002) (1)
- The lymphomas. (1999) (1)
- Cutaneous T cell lymphoma : basic and clinically relevant biology (2001) (1)
- Bone Marrow Involvement in Hodgkin's Disease (HD): Pathology and Clinical Implications. (1973) (1)
- THERAPEUTIC RESEARCH IN THE NATIONAL CANCER INSTITUTE (1984) (1)
- MOPP after two decades. (1987) (1)
- Reversible penile calcifications associated with bleomycin (NSC-125066)-induced pulmonary toxicity. (1975) (1)
- Moral dilemmas in clinical cancer experimentation. (1978) (1)
- Focus issue on biomarkers (2010) (1)
- Advances in the multimodal primary management of cancer. (1980) (1)
- Cancer, the curable diseases. (1980) (1)
- Strong inference (2008) (1)
- Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal. (1973) (1)
- The use of combination chemotherapy in the treatment of early stage Hodgkin's disease. (1992) (1)
- American Burkitt's Lymphoma: Current Status. (1973) (1)
- General progress in clinical chemotherapy of advanced disease. (1980) (1)
- Principles of Cancer Chemotherapy 1 1 Principles of Cancer Chemotherapy (2014) (1)
- Letter: Laparoscopy and laparotomy in staging of Hodgkin's disease. (1976) (0)
- Vincent T. DeVita on His New Book, "The Death of Cancer," and the Current State of Cancer Care. (2016) (0)
- Arteriography of an ileal carcinoid tumor. (1971) (0)
- Disease, Malignant Lymphoma (Hodgkin's Lymphosarcoma, Reticulum Cell Mycosis Fungoides) Sarcoma and (1968) (0)
- Cancer's final act? (2015) (0)
- Invited commentary (1978) (0)
- The dilemma regarding postoperative chemotherapy in primary carcinoma of the colon. (1979) (0)
- The cure of Hodgkin's disease with drugs. (1983) (0)
- DeVita, Hellman, and Rosenberg's cancer vol.1 (2012) (0)
- An Homage to Two Explorers of Uncharted Cancer Waters. (2021) (0)
- Letter from Vincent T. DeVita, Jr. to Joshua Lederberg (1980) (0)
- The Next Fifteen Years (1986) (0)
- Treatment Utopia (2005) (0)
- Future prospectives in the treatment of breast cancer. (1978) (0)
- DeVita responds to Post article. (1981) (0)
- Comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin's lymphoma. [Effectiveness and complications] (1979) (0)
- Intensive Combination Chemotherapy and X-Irradiation in Hodgkin's Disease. (2016) (0)
- Comprar Cancer : Principles and Practice of Oncology Review , 3/e | Ramaswamy Govindan MD | 9781451116397 | Lippincott Williams & Wilkins (2012) (0)
- Follow-up care for survivors of breast and prostate cancer (2005) (0)
- Liver Biopsy in Hodgkin's Disease (2020) (0)
- Washington report: a conversation with Vincent T. DeVita, Jr., M.D.. Interview by Daniel S. Greenberg. (1980) (0)
- Vincent T. DeVita, Jr. Papers Finding Aid (1988) (0)
- On the classification of research. (2002) (0)
- Progress in Oncology 2004 (2004) (0)
- Hodgkin's Disease: An Overview (1978) (0)
- Hodgkin's disease therapeutic program. (1972) (0)
- Management operations of the National Cancer Institute that influence the governance of science. (1984) (0)
- Pyridoxine and anergy in Hodgkin's disease. (1970) (0)
- Symposium on Pneumocystis Carinii Infection : [proceedings], Bethesda, Maryland, December 13-14, 1973 (1976) (0)
- Of mice and men: what animal tests of carcinogens mean to us. (1980) (0)
- 1-(2-CHLOROETHYL)-3-(4-METHYL CYCL0HEXYL)-1- (1972) (0)
- Cancer prevention NCI's primary goal. (1983) (0)
- Gianni Bonadonna, MD: 1934‐2015 (2016) (0)
- On the classification of research (2002) (0)
- Book Review The Story of Taxol: Nature and Politics in the Pursuit of an Anti-Cancer Drug By Jordan Goodman and Vivien Walsh. 282 pp. New York, Cambridge University Press, 2001. $27.95. 0-521-56123-X (2001) (0)
- Leader in war on cancer looks ahead: talking with Vincent T. DeVita, Jr, MD. (1995) (0)
- Relationship to Prognosis of Hodgkin's Disease Phytohemagglutinin-induced Lymphocyte Transformation: The (2011) (0)
- The Year 2000 Award for Mary Lasker (1987) (0)
- Cytoxan vepeside adriamycin methotrexate prednisone nitrogen mustard vincristine procarbazine prednisone combination chemo therapy treatment of diffuse lymphomas (1980) (0)
- The struggles of cancer centers (2009) (0)
- BCG Vaccine Treatment of Hodgkin Disease (1974) (0)
- Health insurance reform—beware of the general solution for the specific problem (2008) (0)
- Shaking chills related to occult lymphoma. Report of a case. (1969) (0)
- Letter: Combination chemotherapy for breast cancer. (1975) (0)
- Cancer Data Defended (1987) (0)
- On clinical alerts. (1991) (0)
- The cancer series: an introduction. (1983) (0)
- A step in the right direction (2006) (0)
- An increasing awareness of pneumocystis carinii pneumonitis. (1972) (0)
- A CONVERSATION WITH VINCENT DEVITA, MD. No Truce Sought in Cancer War: 'We Want to Cure This Disease'. (2016) (0)
- Editorial: Infection and cancer: old friends. (1973) (0)
- PATHOLOGICAL STAGING OF 100 COKSECUTIVE UNTREATED PATIENTS WITH KON-HODGKIN'S LYMPH 0 MAS (1976) (0)
- Cancer journal: From the editors (2001) (0)
- Superiority of ProMACE-CytaBOM Over ProMACE-MOPP in the Treatment of Advanced Diffuse Aggressive Lymphoma (2016) (0)
- The treatment of Hodgkin's disease: emphasizing programs at the Clinic Center, National Institutes of Health. (1977) (0)
- Treatment of Hodgkin's disease in private practice. (1972) (0)
- Introduction. Ovarian cancer, an enigma wrapped in a puzzle. (1975) (0)
- Opinion: A personal note—40 years after the signing of the Cancer Act (2011) (0)
- Breast cancer screening and mortality (2010) (0)
- Comprar Physicians' Cancer Chemotherapy 12ed | Vincent T. DeVita | 9781449646837 | Jones & Bartlett Publishers (2012) (0)
- Hematologic malignancies: non-Hodgkin's lymphomas. (1986) (0)
- News the public should rely on (2009) (0)
- Malignant melanoma: prognostic factors and therapeutic results. (1977) (0)
- Follow-up care for survivors of breast and prostate cancer: primary care physicians must be up-to-date on the new long-term adjuvant treatment options and know how best to minimize long-term effects, particularly on bone health (2005) (0)
- Current chemotherapeutic combinations. (1973) (0)
- Hodgkin's disease [3] (1993) (0)
- Do we need yet another journal? (2004) (0)
- Lung cancer rates are alarming and are NCI's greatest challenge. (1986) (0)
- Pharmacologic aspects of the chemotherapy of solid tumors. (1968) (0)
- Book ReviewFundamentals of Oncology. (1978) (0)
- More on strong inference (2008) (0)
- NCI's breast cancer clinical alert: rationale and results. (1989) (0)
- Overview (1989) (0)
- Advances in cancer therapeutics: chemotherapy. (1983) (0)
- Comprar Physicians' Cancer Chemotherapy Drug Manual 2011 | Vincent T. DeVita Jr. | 9781449601973 | Jones & Bartlett Publishers (2011) (0)
This paper list is powered by the following services:
